NYSEArca - Delayed Quote USD

SPDR?S&P?Biotech ETF (XBI)

100.25 +0.94 (+0.95%)
At close: 4:00 PM EDT
100.12 -0.13 (-0.13%)
After hours: 6:21 PM EDT

Top 10 Holdings (25.73% of Total Assets)

SymbolCompany% Assets
UTHR
United Therapeutics Corporation 2.67%
INCY
Incyte Corporation 2.63%
EXAS
Exact Sciences Corporation 2.63%
ALNY
Alnylam Pharmaceuticals, Inc. 2.62%
ABBV
AbbVie Inc. 2.57%
GILD
Gilead Sciences, Inc. 2.56%
NTRA
Natera, Inc. 2.54%
SRPT
Sarepta Therapeutics, Inc. 2.53%
BIIB
Biogen Inc. 2.51%
MRNA
Moderna, Inc. 2.47%

Sector Weightings

Overall Portfolio Composition (%)

Stocks 99.93%
Bonds 0.00%

Equity Holdings

Price/Earnings 0
Price/Book 0.23
Price/Sales 0.14
Price/Cashflow 0
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").

ETF Overview

Category Health
Fund Family SPDR State Street Global Advisors
Net Assets 7.7B
YTD Daily Total Return 11.38%
Yield 0.15%
Legal Type Exchange Traded Fund

Related Tickers